H1B Salary Data

Home › Employers › Sharp Chula Vista Medical Center

Sharp Chula Vista Medical Center: H-1B salaries and sponsorship

Sharp Chula Vista Medical Center filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $163,166.

Applications (LCAs)4
Certified4
Employer addressChula Vista, CA
H-1B dependent employerNo
Median offered salary$163,166
Middle half of salaries$146,078–$170,789
10th–90th percentile$129,043–$170,789

Does Sharp Chula Vista Medical Center sponsor H-1B visas?

Sharp Chula Vista Medical Center filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 7, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Clinical Nurse4$163,166

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$155,542
FY20251$117,686
FY20262$170,789

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Clinical Nurse$170,789Chula Vista, CAApr 7, 2026Aug 22, 2026Certified
Clinical Nurse$170,789
Level III
Chula Vista, CAMar 11, 2026Aug 22, 2026Certified
Clinical Nurse$117,686–$174,221Chula Vista, CAMay 29, 2025Sep 15, 2025Certified
Clinical Nurse$155,542Chula Vista, CAJun 13, 2023Aug 22, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).